Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children

NCT: NCT06995911 · RECRUITING

NCT IDNCT06995911
StatusRECRUITING
Start Date2025-06-01
Completion2026-05-31

Brief Summary

This clinical trial wants to find out if the Virtual Far-sight Reading Device can help prevent or slow down myopia progression in children and teenagers with pre-myopia. We also want to know what makes this treatment work better for some participants and check for any eye or body-related side effects over time. Main questions: Can using the Virtual Far-sight Reading Device reduce the risk of myopia? Is the device safe to use every day for up to 6 months? What we'll do: Researchers will compare two groups of children: Group A: Uses the device for reading/writing (at least 1 hour daily) Group B: Does regular reading/writing without the device After 90 days, the groups will switch to see if the results stay the same. Participants will: * Have free eye checkups 3 times over 6 months * Use the device during homework time (if in the desk group) * Report any eye discomfort or problems

Frequently Asked Questions

What is Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children?

Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children is a clinical trial registered under NCT06995911. Current status: RECRUITING.

What is the status of NCT06995911?

The current status of NCT06995911 (Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children) is: RECRUITING.

When did Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children start?

Virtual Far-sight Reading Device for Myopia Intervention Among Pre-myopic Children started on 2025-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.